Company: ZVRA
Filing Date: 2025-04-16
Form Type: PRRN14A
Source: 0000897069-25-000815
Chunk: 31

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-16
Form: PRRN14A
Chunk 31
---
 |                                     |               |
| 1,000                 | 11/10/2023                                  |                                     |               |

20 IMPORTANT Tell your Board what you think! Your vote is important. No matter how many shares of Common Stock you own, please give the Proponent your proxy FORthe election of the Nominees and in accordance with the Proponent’s recommendations on the other proposals on the agenda for the Annual Meeting by taking three steps:

| • | SIGNING the enclosedBLUEuniversal proxy card; |

| • | DATING the enclosedBLUEuniversal proxy card; and |

| • | MAILING the enclosedBLUEuniversal proxy card TODAY in the envelope provided (no postage is required if mailed in the United States). |

You may vote your shares at the Annual Meeting, however, even if you plan to attend the Annual Meeting, the Proponent recommends that you submit your BLUEuniversal proxy card by mail by the applicable deadline so that your vote will still be counted if you later decide not to attend the Annual Meeting. If any of your shares of Common Stock are held in the name of a brokerage firm, bank, bank nominee or other institution, only it can vote such shares of Common Stock and only upon receipt of your specific instructions. Depending upon your broker or custodian, you may be able to vote either by toll-free telephone or by the Internet. Please refer to the enclosed voting form for instructions on how to vote electronically. You may also vote by signing, dating and returning the enclosed BLUEvoting form. If you have any questions, require assistance in voting your BLUE universal proxy card, or need additional copies of the Proponent proxy materials, please contact Regan & Associates, Inc. at the email address listed below. Regan & Associates, Inc. 505 Eighth Avenue Suite 800 New York, NY 10018 (800) 737-3426 main@reganproxy.com 21 PRELIMINARY PROXY CARD – SUBJECT TO COMPLETION, DATED APRIL 15, 2025 ZEVRA THERAPEUTICS, INC. 2025 ANNUAL MEETING OF STOCKHOLDERS THIS PROXY IS SOLICITED ON BEHALF OF THE PARTICIPANTS IN ITS PROXY SOLICITATION THE BOARD OF DIRECTORS OF ZEVRA THERAPEUTICS, INC.
IS NOT SOLICITING THIS PROXY P R O X Y The undersigned appoints Daniel J. Mangless and John B. Bode, and each of them, attorneys and